We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cordis Acquires MedAlliance and Its Drug-Eluting Balloon
Cordis Acquires MedAlliance and Its Drug-Eluting Balloon
Cordis has acquired Switzerland-based MedAlliance and its Selution SLR (sustained limus release) drug-eluting balloon — an alternative to the paclitaxel-coated balloons that have raised concerns among regulators because of the risk to patients with peripheral arterial disease (PAD).